Abstract
Glycosylation is one of the most common posttranslational modifications of proteins and can exert profound effects on the inherent properties and biological functions of a given protein. Structurally well-defined homogeneous glycopeptides are highly demanded for functional studies and biomedical applications. Various chemical and chemoenzymatic methods have been reported so far for synthesizing different N- and O-glycopeptides. Among them, the chemoenzymatic method based on an endoglycosidase-catalyzed ligation of free N-glycans and GlcNAc-tagged peptides is emerging as a highly efficient method for constructing large complex N-glycopeptides. This chemoenzymatic approach consists of two key steps. The first step is to prepare the GlcNAc peptide through automated solid-phase peptide synthesis (SPPS) by incorporating an Asn-linked GlcNAc moiety at a predetermined glycosylation site; and the second step is to transfer an N-glycan from the corresponding N-glycan oxazoline en bloc to the GlcNAc peptide by an endoglycosidase or its efficient glycosynthase mutant. In this chapter, we provide detailed procedures of this chemoenzymatic method by demonstrating the synthesis of two HIV-1 V3 glycopeptide antigens carrying a high-mannose-type and a complex-type N-glycan, respectively. The described procedures should be generally applicable for the synthesis of other biologically important N-glycopeptides.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Helenius A, Aebi M (2001) Intracellular functions of N-linked glycans. Science 291:2364–2369
Jefferis R (2009) Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 8:226–234
Hart GW, Copeland RJ (2010) Glycomics hits the big time. Cell 143:672–676
Moremen KW, Tiemeyer M, Nairn AV (2012) Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 13:448–462
Varki A (2017) Biological roles of glycans. Glycobiology 27:3–49
Payne RJ, Wong CH (2010) Advances in chemical ligation strategies for the synthesis of glycopeptides and glycoproteins. Chem Commun (Camb) 46:21–43
Unverzagt C, Kajihara Y (2013) Chemical assembly of N-glycoproteins: a refined toolbox to address a ubiquitous posttranslational modification. Chem Soc Rev 42:4408–4420
Wilson RM, Dong S, Wang P et al (2013) The winding pathway to erythropoietin along the chemistry-biology frontier: a success at last. Angew Chem Int Ed 52:7646–7665
Wang P, Dong S, Shieh JH et al (2013) Erythropoietin derived by chemical synthesis. Science 342:1357–1360
Murakami M, Kiuchi T, Nishihara M et al (2016) Chemical synthesis of erythropoietin glycoforms for insights into the relationship between glycosylation pattern and bioactivity. Sci Adv 2:e1500678
Aussedat B, Fasching B, Johnston E et al (2012) Total synthesis of the alpha-subunit of human glycoprotein hormones: toward fully synthetic homogeneous human follicle-stimulating hormone. J Am Chem Soc 134:3532–3541
Nagorny P, Sane N, Fasching B et al (2012) Probing the frontiers of glycoprotein synthesis: the fully elaborated beta-subunit of the human follicle-stimulating hormone. Angew Chem Int Ed 51:975–979
Aussedat B, Vohra Y, Park PK et al (2013) Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines. J Am Chem Soc 135:13113–13120
Yamamoto N, Tanabe Y, Okamoto R et al (2008) Chemical synthesis of a glycoprotein having an intact human complex-type sialyloligosaccharide under the Boc and Fmoc synthetic strategies. J Am Chem Soc 130:501–510
Sakamoto I, Tezuka K, Fukae K et al (2012) Chemical synthesis of homogeneous human glycosyl-interferon-beta that exhibits potent antitumor activity in vivo. J Am Chem Soc 134:5428–5431
Wang LX, Amin MN (2014) Chemical and chemoenzymatic synthesis of glycoproteins for deciphering functions. Chem Biol 21:51–66
Fairbanks AJ (2017) The ENGases: versatile biocatalysts for the production of homogeneous N-linked glycopeptides and glycoproteins. Chem Soc Rev 46:5128–5146
Li C, Wang LX (2018) Chemoenzymatic methods for the synthesis of glycoproteins. Chem Rev 118:8359–8413
Umekawa M, Li C, Higashiyama T et al (2010) Efficient glycosynthase mutant derived from Mucor hiemalis endo-beta-N-acetylglucosaminidase capable of transferring oligosaccharide from both sugar oxazoline and natural N-glycan. J Biol Chem 285:511–521
Umekawa M, Huang W, Li B et al (2008) Mutants of Mucor hiemalis endo-beta-N-acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities. J Biol Chem 283:4469–4479
Huang W, Li C, Li B et al (2009) Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans. J Am Chem Soc 131:2214–2223
Giddens JP, Lomino JV, Amin MN et al (2016) Endo-F3 glycosynthase mutants enable chemoenzymatic synthesis of core-fucosylated triantennary complex type glycopeptides and glycoproteins. J Biol Chem 291:9356–9370
Huang W, Giddens J, Fan SQ et al (2012) Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions. J Am Chem Soc 134:12308–12318
Li T, Tong X, Yang Q et al (2016) Glycosynthase mutants of endoglycosidase S2 show potent transglycosylation activity and remarkably relaxed substrate specificity for antibody glycosylation remodeling. J Biol Chem 291:16508–16518
Priyanka P, Parsons TB, Miller A et al (2016) Chemoenzymatic synthesis of a phosphorylated glycoprotein. Angew Chem Int Ed 55:5058–5061
Yamaguchi T, Amin MN, Toonstra C et al (2016) Chemoenzymatic synthesis and receptor binding of mannose-6-phosphate (M6P)-containing glycoprotein ligands reveal unusual structural requirements for M6P receptor recognition. J Am Chem Soc 138:12472–12485
Amin MN, Mclellan JS, Huang W et al (2013) Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies. Nat Chem Biol 9:521–526
Toonstra C, Amin MN, Wang LX (2016) Site-selective chemoenzymatic glycosylation of an HIV-1 polypeptide antigen with two distinct N-glycans via an orthogonal protecting group strategy. J Org Chem 81:6176–6185
Orwenyo J, Cai H, Giddens J et al (2017) Systematic synthesis and binding study of HIV V3 glycopeptides reveal the fine epitopes of several broadly neutralizing antibodies. ACS Chem Biol 12:1566–1575
Cai H, Orwenyo J, Guenaga J et al (2017) Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies. Chem Commun (Camb) 53:5453–5456
Cai H, Orwenyo J, Giddens JP et al (2017) Synthetic three-component HIV-1 V3 glycopeptide immunogens induce glycan-dependent antibody responses. Cell Chem Biol 24:1513–1522.e4
Cai H, Zhang R, Orwenyo J et al (2018) Multivalent antigen presentation enhances the immunogenicity of a synthetic three-component HIV-1 V3 glycopeptide vaccine. ACS Cent Sci 4:582–589
Cai H, Zhang RS, Orwenyo J et al (2018) Synthetic HIV V3 glycopeptide immunogen carrying a N334 N-glycan induces glycan-dependent antibodies with promiscuous site recognition. J Med Chem 61:10116–10125
Lin CW, Tsai MH, Li ST et al (2015) A common glycan structure on immunoglobulin G for enhancement of effector functions. Proc Natl Acad Sci U S A 112:10611–10616
Kurogochi M, Mori M, Osumi K et al (2015) Glycoengineered monoclonal antibodies with homogeneous glycan (M3, G0, G2, and A2) using a chemoenzymatic approach have different affinities for FcgammaRIIIa and variable antibody-dependent cellular cytotoxicity activities. PLoS One 10:e0132848
Giddens JP, Wang LX (2015) Chemoenzymatic glyco-engineering of monoclonal antibodies. Methods Mol Biol 1321:375–387
Quast I, Keller CW, Maurer MA et al (2015) Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J Clin Invest 125:4160–4170
Parsons TB, Struwe WB, Gault J et al (2016) Optimal synthetic glycosylation of a therapeutic antibody. Angew Chem Int Ed 55:2361–2367
Liu R, Giddens J, Mcclung CM et al (2016) Evaluation of a glycoengineered monoclonal antibody via LC-MS analysis in combination with multiple enzymatic digestion. MAbs 8:340–346
Li T, Dilillo D, Bournazos S et al (2017) Modulating IgG effector functions by Fc glycan engineering. Proc Natl Acad Sci U S A 114:3485–3490
Giddens JP, Lomino JV, Dilillo DJ et al (2018) Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody. Proc Natl Acad Sci U S A 115:12023–12027
Acknowledgments
This work was supported by the National Institutes of Health (NIH grants R01GM080374 and R01GM096973 to L.X.W.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zong, G., Li, C., Wang, LX. (2020). Chemoenzymatic Synthesis of HIV-1 Glycopeptide Antigens. In: Hussein, W., Skwarczynski, M., Toth, I. (eds) Peptide Synthesis. Methods in Molecular Biology, vol 2103. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0227-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0227-0_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0226-3
Online ISBN: 978-1-0716-0227-0
eBook Packages: Springer Protocols